hypertensive encephalopathy/potássio

O link é salvo na área de transferência

ArtigosTestes clínicosPatentes

Escolha o tipo de classificação

6 resultados

A case of Liddle's syndrome; unusual presentation with hypertensive encephalopathy.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Liddle's syndrome is a rare cause of secondary hypertension. Identification of this disorder is important because treatment differs from other forms of hypertension. We report an interesting case of a 35-year-old lady, a known diabetic and hypertensive patient, who presented with features of

Seizure and coma secondary to Conn's syndrome: a case report

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Background: Conn's syndrome is a curable condition if identified properly. It is characterized by autonomous secretion of aldosterone from the adrenal gland cortex. Its morbidity is related to the increased risk of cardiovascular

Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND A 49-year-old woman was admitted to our hospital because of thunderclap headache and blurred vision. At the time of presentation, her blood pressure was 219/100 mmHg, her arterial pH was 7.64 and her potassium level was 2.7 mM/l. METHODS The combination of sequential computed tomography

[Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

18 anemic patients undergoing maintenance hemodialysis were treated with recombinant human erythropoietin (EPO) 1-3 times per week for 10.7 +/- 3 months. 4 patients underwent renal transplantation whereas 14 patients could be followed up during 12 months of EPO treatment. Hemoglobin concentration

Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Twelve anaemic patients on haemodialysis were treated with recombinant human erythropoietin, starting with 72 IU/kg/week. The dose was doubled after 2 weeks until an increase of 2 g/dl of haemoglobin was observed. The effects on various parameters were studied during a 3-month period. Haemoglobin

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE To determine the effectiveness and safety of recombinant human erythropoietin (rHuEpo). METHODS Hemodialysis patients (333) with uncomplicated anemia (hematocrit less than 0.30). All received rHuEpo intravenously, three times per week at 300 or 150 U/kg body weight, which was then reduced

Junte-se à nossa
página do facebook

Herbal & Natural Medicine

O mais completo banco de dados de ervas medicinais apoiado pela ciência

Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas